GLORY: Glofit-GemOx With Liso-Cel For Lymphoma

NCT07711483 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
B-cell Lymphomas
Relapsed/Refractory Large B-cell Lymphoma
Large B-cell Lymphoma

Interventions

DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Gemcitabine & oxaliplatin
PROCEDURE: Leukapheresis
DRUG: Lymphodepleting chemotherapy
DRUG: LISOCABTAGENE MARALEUCEL

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]